0
Applied AI·August 7, 2026·1 min read

Stanford is running 37,000 AI agents as a virtual biotech — and one of its drug designs got independently confirmed by Merck

Share

37,000 concurrent agents producing a drug design that Merck independently confirms is a proof point for agent swarms as R&D infrastructure, not a demo. If you run any search-heavy or combinatorial pipeline—drug, chip, logistics—you should be scoping where a multi-agent fabric could replace years of human iteration.

Applied AI

Shock horror — AI-generated security patches fall short of actually solving all the problems they were meant to fix

Automated patch generation without human review is now a documented risk surface — AI-written fixes that only partially remediate or introduce new bugs turn security into theater. If you’re piloting AI for remediation, keep it in “assistant” mode: require code review, expand test coverage around AI patches, and track defect rates separately from human-written fixes.